Verseau Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$50M
- Investors
-
8
Verseau Therapeutics General Information
Description
Developer of macrophage checkpoint modulators designed to benefit patients with cancer. The company's technology utilizes lipid nanoparticles to identify novel targets and develop therapies that shift macrophages between immune activators and silencers, enabling physicians to provide patients with immunotherapies that induce a coordinated immune response to fight tumors.
Contact Information
Website
www.verseautx.comCorporate Office
- 2000 Commonwealth Avenue
- Suite 110
- Auburndale, MA 02466
- United States
Corporate Office
- 2000 Commonwealth Avenue
- Suite 110
- Auburndale, MA 02466
- United States
Verseau Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 21-Oct-2019 | $50M | Completed | Pre-Clinical Trials | ||
| 2. Early Stage VC (Series B) | 12-Feb-2019 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC (Series A) | 30-Oct-2017 | $4.3M | $4.3M | Completed | Pre-Clinical Trials |
Verseau Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Verseau Therapeutics Comparisons
Industry
Financing
Details
Verseau Therapeutics Competitors (21)
One of Verseau Therapeutics’s 21 competitors is APEIRON Biologics, a Formerly VC-backed company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| APEIRON Biologics | Formerly VC-backed | Vienna, Austria | ||||
| Noveome Biotherapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
Verseau Therapeutics Patents
Verseau Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021281356-A1 | Anti-vsig4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | Pending | 29-May-2020 | ||
| CA-3182814-A1 | Anti-vsig4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | Pending | 29-May-2020 | ||
| EP-4157886-A1 | Anti-vsig4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | Pending | 29-May-2020 | ||
| EP-4157886-A4 | Anti-vsig4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | Pending | 29-May-2020 | ||
| US-12742011-B2 | Anti-vsig4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | Active | 29-May-2020 | C07K16/2827 |
Verseau Therapeutics Signals
Verseau Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| InHarv Partners | Venture Capital | Minority | ||
| 3Sbio | Corporation | Minority | ||
| 20/20 HealthCare Partners | Family Office | Minority | ||
| Alexandria Real Estate Equities | Real Estate | Minority |
Verseau Therapeutics FAQs
-
When was Verseau Therapeutics founded?
Verseau Therapeutics was founded in 2017.
-
Where is Verseau Therapeutics headquartered?
Verseau Therapeutics is headquartered in Auburndale, MA.
-
What is the size of Verseau Therapeutics?
Verseau Therapeutics has 16 total employees.
-
What industry is Verseau Therapeutics in?
Verseau Therapeutics’s primary industry is Drug Discovery.
-
Is Verseau Therapeutics a private or public company?
Verseau Therapeutics is a Private company.
-
What is Verseau Therapeutics’s current revenue?
The current revenue for Verseau Therapeutics is .
-
How much funding has Verseau Therapeutics raised over time?
Verseau Therapeutics has raised $69.3M.
-
Who are Verseau Therapeutics’s investors?
Alexandria Venture Investments, InHarv Partners, 3Sbio, 20/20 HealthCare Partners, and Alexandria Real Estate Equities are 5 of 8 investors who have invested in Verseau Therapeutics.
-
Who are Verseau Therapeutics’s competitors?
APEIRON Biologics, Noveome Biotherapeutics, Adaptimmune Therapeutics, Carisma Therapeutics, and Inovio Pharmaceuticals are some of the 21 competitors of Verseau Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process